KBC Group NV Cuts Position in Molina Healthcare, Inc $MOH

KBC Group NV reduced its holdings in shares of Molina Healthcare, Inc (NYSE:MOHFree Report) by 32.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 85,350 shares of the company’s stock after selling 40,871 shares during the quarter. KBC Group NV’s holdings in Molina Healthcare were worth $25,426,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD grew its stake in shares of Molina Healthcare by 46.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock valued at $1,264,214,000 after acquiring an additional 1,216,903 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its position in Molina Healthcare by 8.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock valued at $490,099,000 after purchasing an additional 117,796 shares during the period. AQR Capital Management LLC boosted its stake in Molina Healthcare by 42.7% during the 1st quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock valued at $288,125,000 after purchasing an additional 264,664 shares during the period. Durable Capital Partners LP raised its stake in Molina Healthcare by 13.1% during the 1st quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock valued at $178,399,000 after acquiring an additional 62,899 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Molina Healthcare by 1.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 465,672 shares of the company’s stock worth $153,388,000 after purchasing an additional 7,021 shares during the period. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Stock Performance

NYSE MOH opened at $138.51 on Friday. The company has a 50 day moving average of $177.05 and a 200-day moving average of $221.23. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.92. The firm has a market cap of $7.51 billion, a price-to-earnings ratio of 8.58 and a beta of 0.55. Molina Healthcare, Inc has a 1-year low of $138.26 and a 1-year high of $359.97.

Molina Healthcare (NYSE:MOHGet Free Report) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The business had revenue of $11.48 billion during the quarter, compared to the consensus estimate of $10.99 billion. During the same period in the prior year, the firm earned $6.01 earnings per share. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. On average, equities analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Cantor Fitzgerald decreased their target price on Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating for the company in a research note on Friday, October 24th. Robert W. Baird decreased their price target on shares of Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating for the company in a report on Friday, July 25th. Wall Street Zen lowered Molina Healthcare from a “hold” rating to a “sell” rating in a report on Saturday, October 25th. TD Cowen cut Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 target price for the company. in a research report on Thursday, October 16th. Finally, The Goldman Sachs Group lowered their target price on Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating on the stock in a report on Friday, October 24th. Three equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $198.93.

Read Our Latest Stock Analysis on MOH

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Recommended Stories

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOHFree Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.